US Senator Sanders optimistic Novo Nordisk can be pressured to cut Wegovy, Ozempic prices

Senator Bernie Sanders on Wednesday expressed confidence that Novo Nordisk (NOVOb.CO) can be convinced to cut the U.S. prices of its popular Ozempic and Wegovy drugs used for weight loss by publicly shaming the company over how much it charges compared with prices in other countries.